Χώρα: Πορτογαλία
Γλώσσα: Πορτογαλικά
Πηγή: INFARMED (Autoridade Nacional do Medicamento e Produtos de Saúde)
Dutasterida + Tansulosina
Pharmakern Portugal - Produtos Farmacêuticos, Sociedade Unipessoal, Lda.
G04CA52
Dutasteride + Tamsulosin
0.5 mg + 0.4 mg
Cápsula
Dutasterida 0.5 mg ; Tansulosina, cloridrato 0.4 mg
Via oral
Frasco 30 unidade(s)
7.4.2.1 - Medicamentos usados na retenção urinária
MSRM
Genérico
tamsulosin and dutasteride
Duração do Tratamento: Longa Duração
Número de Registo: 5779814 CNPEM: 50119281 CHNM: 10100248 Comercializado
Autorizado
2019-08-23
$3529$'2(0 ,1)$50(' )ROKHWR,QIRUPDWLYR,QIRUPD©¥RSDUDRXWLOL]DGRU 'XWDVWHULGD7DQVXORVLQD%HWXGHPJPJF£SVXODV 'XWDVWHULGDFORULGUDWRGHWDQVXORVLQD /HLDFRPDWHQ©¥RWRGRHVWHIROKHWRDQWHVGHFRPH©DUDWRPDUHVWHPHGLFDPHQWRSRLV FRQW«PLQIRUPD©¥RLPSRUWDQWHSDUDVL &RQVHUYHHVWHIROKHWR3RGHWHUQHFHVVLGDGHGHROHUQRYDPHQWH &DVRDLQGDWHQKDG¼YLGDVIDOHFRPRVHXP«GLFRRXIDUPDF¬XWLFR (VWHPHGLFDPHQWRIRLUHFHLWDGRDSHQDVSDUDVL1¥RGHYHG£ORDRXWURV2 PHGLFDPHQWRSRGHVHUOKHVSUHMXGLFLDOPHVPRTXHDSUHVHQWHPRVPHVPRVVLQDLVGH GRHQ©D 6HWLYHUTXDLVTXHUHIHLWRVLQGHVHM£YHLVLQFOXLQGRSRVV¯YHLVHIHLWRVLQGHVHM£YHLVQ¥R LQGLFDGRVQHVWHIROKHWRIDOHFRPRVHXP«GLFRRXIDUPDF¬XWLFR9HUVHF©¥R 2TXHFRQW«PHVWHIROKHWR 2TXH«'XWDVWHULGD7DQVXORVLQD%HWXGHHSDUDTXH«XWLOL]DGR 2TXHSUHFLVDGHVDEHUDQWHVGHWRPDU'XWDVWHULGD7DQVXORVLQD%HWXGH &RPRWRPDU'XWDVWHULGD7DQVXORVLQD%HWXGH (IHLWRVLQGHVHM£YHLVSRVV¯YHLV &RPRFRQVHUYDU'XWDVWHULGD7DQVXORVLQD%HWXGH &RQWH¼GRGDHPEDODJHPHRXWUDVLQIRUPD©·HV 2TXH«'XWDVWHULGD7DQVXORVLQD%HWXGHHSDUDTXH«XWLOL]DGR $3529$'2(0 ,1)$50(' 'XWDVWHULGD7DQVXORVLQD%HWXGH«XWLOL]DGRQRWUDWDPHQWRGHKRPHQVFRPXP DXPHQWRGRYROXPHGDSUµVWDWDKLSHUSODVLDEHQLJQDGDSUµVWDWDFUHVFLPHQWRQ¥R FDQFHURVRGDSUµVWDWDFDXVDGRSRUH[FHVVLYDSURGX©¥RGHXPDKRUPRQDGHQRPLQDGD GLKLGURWHVWRVWHURQD 'XWDVWHULGD7DQVXORVLQD%HWXGH«XPDDVVRFLD©¥RGHGRLVPHGLFDPHQWRVGLIHUHQWHV GHQRPLQDGRVGXWDVWHULGDHWDQVXORVLQD$GXWDVWHULGDSHUWHQFHDRJUXSRGH PHGLFDPHQWRVGHQRPLQDGRVLQLELGRUHVGDDOIDUHGXWDVHHDWDQVXORVLQDSHUWHQFHDR JUXSRGHPHGLFDPHQWRVGHQRPLQDGRVEORTXHDGRUHVDOID 2FUHVFLPHQWRGDSUµVWDWDSRGHOHYDUDGLVW¼UELRVXULQ£ULRVWDLVFRPRGLILFXOGDGHQD SDVVDJHPGDXULQDHQHFHVVLGDGHPDLVIUHTXHQWHGHLU¢FDVDGHEDQKR3RGHWDPE«P FDXVDURIOX[RXULQ Διαβάστε το πλήρες έγγραφο
$3529$'2(0 ,1)$50(' 5(6802'$6&$5$&7(567,&$6'20(',&$0(172 120('20(',&$0(172 'XWDVWHULGD7DQVXORVLQD%HWXGHPJPJF£SVXODV &20326, 248$/,7$7,9$(48$17,7$7,9$ &DGDF£SVXODFRQW«PPJGHGXWDVWHULGDHPJGHFORULGUDWRGHWDQVXORVLQD HTXLYDOHQWHDPJGHWDQVXORVLQD ([FLSLHQWHVFRPHIHLWRFRQKHFLGR 3RGHFRQWHUYHVW¯JLRVGHOHFLWLQDGHVRMDSRGHFRQWHUµOHRGHVRMD /LVWDFRPSOHWDGHH[FLSLHQWHVYHUVHF©¥R )250$)$50$&87,&$ &£SVXOD &£SVXODVREORQJDVFRPFRUSRFDVWDQKRHFDEH©DEHJHLPSUHVVDFRP&DWLQWD SUHWDQ|(/ &DGDF£SVXODFRQW«PSHOOHWVGHOLEHUWD©¥RPRGLILFDGDGHFORULGUDWRGHWDQVXORVLQDH XPDF£SVXODGHJHODWLQDPROHGHGXWDVWHULGD ,1)250$(6&/1,&$6 ,QGLFD©·HVWHUDS¬XWLFDV 7UDWDPHQWRGHVLQWRPDVPRGHUDGRVDJUDYHVGDKLSHUSODVLDEHQLJQDGDSUµVWDWD+%3 5HGX©¥RGRULVFRGHUHWHQ©¥RXULQ£ULDDJXGD58$HFLUXUJLDHPGRHQWHVFRP VLQWRPDVGH+%3PRGHUDGRVDJUDYHV $3529$'2(0 ,1)$50(' 3DUDLQIRUPD©¥RDFHUFDGRVHIHLWRVGRWUDWDPHQWRHSRSXOD©·HVGHGRHQWHVHVWXGDGDV QRVHQVDLRVFO¯QLFRVYHUVHF©¥R 3RVRORJLDHPRGRGHDGPLQLVWUD©¥R 3RVRORJLD $GXOWRVLQFOXLQGRLGRVRV $GRVHUHFRPHQGDGDGH'XWDVWHULGD7DQVXORVLQD%HWXGH«GHXPDF£SVXODPJ PJSRUGLD 4XDQGRDSURSULDGR'XWDVWHULGD7DQVXORVLQD%HWXGHSRGHU£VHUXWLOL]DGRSDUD VXEVWLWXLUDGXWDVWHULGDHRFORULGUDWRGHWDQVXORVLQDGDWHUDS¬XWLFDGXSODSUHFRQL]DGD SDUDVLPSOLILFDURWUDWDPHQWR 4XDQGRFOLQLFDPHQWHDSURSULDGRSRGHU£VHUFRQVLGHUDGDDSDVVDJHPGLUHWDGD PRQRWHUDSLDFRPGXWDVWHULGDRXFORULGUDWRGHWDQVXORVLQDSDUD'XWDVWHULGD 7DQVXORVLQD%HWXGH &RPSURPLVVRUHQDO 1¥RIRLHVWXGDGRRHIHLWRGRFRPSURPLVVRUHQDOQDIDUPDFRFLQ«WLFDGHGXWDVWHULGD WDQVXORVLQD 1¥R«VXJHULGRDMXVWHSRVROµJLFRSDUDGRHQWHVFRPFRPSURPLVVRUHQDOYHUVHF©¥R H &RPSURPLVVRKHS£WLFR 1¥RIRLHVWXGDGRRHIHLWRGRFRPSURPLVVR Διαβάστε το πλήρες έγγραφο